A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Iron Overload in Allogeneic Hematopoietic Cell Transplantation Outcome: A Meta-Analysis




TekijätPhilippe Armand, Haesook T. Kim, Johanna M. Virtanen, Riitta K. Parkkola, Maija A. Itälä-Remes, Navneet S. Majhail, Linda J. Burns, Todd DeFor, Bryan Trottier, Uwe Platzbecker, Joseph H. Antin, Martin Wermke

KustantajaElsevier Inc.

Julkaisuvuosi2014

JournalBiology of Blood and Marrow Transplantation

Tietokannassa oleva lehden nimiBiology of Blood and Marrow Transplantation

Vuosikerta20

Numero8

Aloitussivu1248

Lopetussivu1251

Sivujen määrä4

ISSN1523-6536

DOIhttps://doi.org/10.1016/j.bbmt.2014.04.024

Verkko-osoitehttp://api.elsevier.com/content/abstract/scopus_id:84904065494


Tiivistelmä

An elevated ferritin level before allogeneic hematopoietic cell transplantation (HCT) is an adverse prognostic factor for overall survival (OS) and nonrelapse mortality. Because ferritin is an imperfect surrogate of iron stores, the prognostic role of iron overload remains unclear. We conducted a patient-level meta-analysis of 4studies that used magnetic resonance imaging to estimate pre-HCT liver iron content (LIC). An elevated LIC was not associated with a significant increase in mortality: the hazard ratio (HR) for mortality associated with LIC>7mg/g dry weight (primary endpoint) was 1.4 (P= .18). In contrast, ferritin >1000ng/mL was a significant prognostic factor (HR for mortality, 1.7; P= .036). There was, however, no significant association between ferritin > 2500 and mortality. This meta-analysis suggests that iron overload, as assessed by LIC, is not a strong prognostic factor for OS in a general adult HCT population. Our data also suggest that ferritin is an inadequate surrogate for iron overload in HCT. © 2014 American Society for Blood and Marrow Transplantation.




Last updated on 2024-26-11 at 11:06